Abstract
The objective of this research was to examine the correlation between the status of inactivated COVID-19 vaccination and self-reported confirmed SARS-CoV-2 infection among adults after China entered the "living with COVID” era. A cross-sectional online survey was conducted among parents or guardians of students attending all 220 kindergartens and 105 primary or secondary schools in Longhua District of Shenzhen, China during March 1 to 9, 2023. The participating schools invited all parents or guardians of their students to complete the online survey. The study focused on a sub-sample of 68,584 participants who were either unvaccinated (n = 2152) or only receiving inactivated COVID-19 vaccination (n = 66,432). Logistic regression was employed for data analysis. Prior to the implementation of the “living with COVID” policy, 83.5% of the participants received three doses of inactivated COVID-19 vaccines; 63.0% reported being infected with the SARS-CoV-2 after the policy change. In a multivariate analysis, participants who had received a third dose within the past 6 months were less likely to be infected with SARS-CoV-2, as compared to those who had not completed the primary vaccination series (4–6 months: AOR: 0.84, 95%CI: 0.77, 0.92; ≤3 months: AOR: 0.82, 95%CI: 0.73, 0.92). Despite the high coverage, our results suggested that three doses of inactivated COVID-19 vaccines did not provide adequate protection against SARS-CoV-2 infection among Chinese adults. Copyright © 2024 The Authors.
Original language | English |
---|---|
Article number | e25803 |
Journal | Heliyon |
Volume | 10 |
Issue number | 4 |
Early online date | Feb 2024 |
DOIs | |
Publication status | Published - Feb 2024 |
Citation
Chen, H., Chen, S., Liu, L., Fang, Y., Liang, X., Liang, D., Su, L., Peng, W., Zhou, X., Luo, J., & Wang, Z. (2024). Inactivated COVID-19 vaccination and SARS-CoV-2 infection among Chinese adults in the “living with COVID” era. Heliyon, 10(4), Article e25803. https://doi.org/10.1016/j.heliyon.2024.e25803Keywords
- Inactivated COVID-19 vaccination
- Booster dose
- SARS-CoV-2 infection
- Adults
- China